Idarubicin C26H27NO9 CAS NO.58957-92-9

FOB Price:: USD 1.00-1.00 /Kilogram Get Latest Price

Min.Order Quantity:: 1 Kilogram

Purity:: 99%min

Port:: Shanghai

Payment Terms:: L/C,D/A,D/P,T/T,

Add to Inquiry Cart

Product Details

Keywords

58957-92-9
Idarubicin
IDA

Quick Details

ProName: Idarubicin C26H27NO9
CasNo: 58957-92-9
Molecular Formula: C26H27NO9
Appearance: White to off- white powder
Application: Metabolism Drug; Carcino-Chemotherapeu...
DeliveryTime: one week
PackAge: 25kg/drum
Port: Shanghai
ProductionCapacity: 200 Kilogram/Day
Purity: 99%min
Storage: RT
Transportation: BY SEA,AIR
LimitNum: 1 Kilogram
Related Substances: 0.1%
Residue on Ignition: 0.2%
Heavy Metal: 10ppm
Valid Period: 2years
CAS: 58957-92-9

Superiority

ida is a derivative of daunorubicin, can interfere with the dnr as the activity oftopoisomerase ⅱ, inhibition of dna synthesis.it with other anthracyclines the main difference between the structures division in the c4position of its removal of a glycosidic methoxy, fat-soluble higher than other more susceptible to anthracycline cellular uptake, and thus play a greater role in cell killing.

Details

?descriptions of idarubicin 58957-92-9

product name: idarubicin

inchl: inchi=1/c26h27no9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34h,7-9,27h2,1-2h3/t10-,15-,16-,17-,21+,26-/m0/s1

mf: c26h28clno9

mw: 497.49

cas: c26h27no9

assay: 99%

indication: acute non-lymphoblastic leukemia, acute lymphoblastic leukemia, non-hodgkin's

disease, advanced breast cancer, multiple myeloma

Post a RFQ

Cas No.:

Product Name:

Quantity: